Stockreport

Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirement to Timely File Annual Report on Form 10-K

Eagle Pharmaceuticals, Inc.  (EGRX) 
Last eagle pharmaceuticals, inc. earnings: 3/2 06:50 am Check Earnings Report
US:NASDAQ Investor Relations: investor.eagleus.com
PDF WOODCLIFF LAKE, N.J., April 12, 2024 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (the “Company”) today announced that it received a notice (the “Not [Read more]